Natrecor Information
What is Natrecor?
Natrecor® is the name under which Scios, a Johnson & Johnson company, markets a prescription medication for patients with acutely decompensated congestive heart failure, generically called nesiritide. Natrecor also targets the dyspnea, or shortness of breath, which can accompany heart failure.
- Should Heart Failure Drug Natrecor Be Recalled Due to Safety Questions?
- A July 14, 2005 article by renowned cardiologist Eric J. Topol in the The New England Journal of Medicine prompted letters to the editor supporting and disputing Dr. Topol's concerns. The letters were published, along with Dr. Topol's reply, in the NEJM's October 6, 2005 edition.
- Natrecor Maker Scios Gets Subpoena: Boston US Attorney's Office Requesting Documents Related to the Sales and Marketing of Natrecor
- Johnson & Johnson's aggressive marketing of its heart-failure treatment Natrecor has become the subject of an inquiry by the Justice Department. Johnson & Johnson subsidiary Scios received a subpoena from Michael Sullivan of the U.S. Attorney's Office in Massachusetts on July 21, 2005 over its marketing of Natrecor. The subpoena followed allegations from some doctors that Scios has been promoting off-label uses of the drug.
- Natrecor Dear Doctor Letters May 2005 and July 2005
- On May 6, 2005, Scios and the FDA notified health care professionals of revisions to the Adverse Reactions/Effect on Mortality section of the prescribing information for Natrecor in an April Dear Doctor letter, and on July 13, 2005, a second Dear Doctor letter was issued to advise health care professionals that the use of Natrecor should be strictly limited to patients presenting to the hospital with acutely decompensated congestive heart failure who have dyspnea at rest.
- Natrecor Class Actions
- Our law firm believes that people injured by Natrecor are better served by having an individual lawsuit filed instead of joining a class action lawsuit.
- Natrecor and Legal Compensation
- How to get legal compensation for a Natrecor injury or death.
- Natrecor Case Evaluation
|
